Could gene edits solve obstacles to treatment for the most common types of cancer?

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to treat patients with blood cancers such as leukemia. But when it comes to treating solid tumor cancers, such as lung, breast…

Continue Reading

News Source: medicalxpress.com